CD4 T-cell hyporesponsiveness induced by schistosome larvae is not dependent upon eosinophils but may involve connective tissue mast cells

Parasite Immunology

Volumn 38, Issue 2, 2016, Pages 81-92

  Prendergast, C T ^a,b   Sanin, D E ^a,c   Mountford, A P ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

Author keywords

CD4 T lymphocytes < cell; Eosinophil < cell; Immune modulation < immunological terms; Mast cell < cell; Schistosomiasis < disease

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PARASITE ANTIGEN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CONNECTIVE TISSUE CELL; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHIL; EOSINOPHILIA; IMMUNE RESPONSE; IN VITRO STUDY; LARVA; LYMPH NODE; MACROPHAGE; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SKIN BIOPSY; SKIN CELL; SKIN INFECTION; ANIMAL; C57BL MOUSE; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LEUKOCYTE COUNT; PARASITOLOGY;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CONNECTIVE TISSUE CELLS; EOSINOPHILS; IMMUNE TOLERANCE; INTERLEUKIN-10; LARVA; LEUKOCYTE COUNT; MAST CELLS; MICE; MICE, INBRED C57BL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SKIN DISEASES, INFECTIOUS;

EID: 84955571608     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/pim.12300     Document Type: Article

References (47)

1. Chitsulo L, Loverde P & Engels D. Schistosomiasis. Nat Rev Microbiol 2004; 2: 12-13.
2. Colley DG, Bustinduy AL, Secor WE & King CH. Human schistosomiasis. Lancet 2014; 383: 2253-2264.
3. Paveley RA, Aynsley SA, Cook PC, Turner JD & Mountford AP. Fluorescent imaging of antigen released by a skin-invading helminth reveals differential uptake and activation profiles by antigen presenting cells. PLoS Negl Trop Dis 2009; 3: e528.
4. Cook PC, Aynsley SA, Turner JD, et al. Multiple helminth infection of the skin causes lymphocyte hypo-responsiveness mediated by Th2 conditioning of dermal myeloid cells. PLoS Pathog 2011; 7: e1001323.
5. Domingo EO & Warren KS. Endogenous desensitization: changing host granulomatou response to schistosome eggs at different stages of infection with schistosoma mansoni. Am J Pathol 1968; 52: 369-379.
6. Colley DG, Barsoum IS, Dahawi HS, Gamil F, Habib M & el Alamy MA. Immune responses and immunoregulation in relation to human schistosomiasis in Egypt. III. Immunity and longitudinal studies of in vitro responsiveness after treatment. Trans R Soc Trop Med Hyg 1986; 80: 952-957.
7. Grogan JL, Kremsner PG, Deelder AM & Yazdanbakhsh M. Antigen-specific proliferation and interferon-gamma and interleukin-5 production are down-regulated during Schistosoma haematobium infection. J Infect Dis 1998; 177: 1433-1437.
8. Turner JD, Jenkins GR, Hogg KG, et al. CD4+CD25+ regulatory cells contribute to the regulation of colonic Th2 granulomatous pathology caused by schistosome infection. PLoS Negl Trop Dis 2011; 5: e1269.
9. Taylor JJ, Mohrs M & Pearce EJ. Regulatory T cell responses develop in parallel to Th responses and control the magnitude and phenotype of the Th effector population. J Immunol 2006; 176: 5839-5847.
10. Hesse M, Piccirillo CA, Belkaid Y, et al. The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. J Immunol 2004; 172: 3157-3166.
11. Pearce EJ & MacDonald AS. The immunobiology of schistosomiasis. Nat Rev Immunol 2002; 2: 499-511.
12. Prendergast CT, Sanin DE, Cook PC & Mountford AP. CD4+ T cell hyporesponsiveness after repeated exposure to Schistosoma mansoni larvae is dependent upon interleukin-10. Infect Immun 2015; 83: 1418-1430.
13. Sanin DE, Prendergast CT, Bourke CD & Mountford AP. Helminth infection and commensal microbiota drive early IL-10 production in the skin by CD4+ T cells that are functionally suppressive. PLoS Pathog 2015; 11: e1004841.
14. Bourke CD, Prendergast CT, Sanin DE, Oulton TE, Hall RJ & Mountford AP. Epidermal keratinocytes initiate wound healing and pro-inflammatory immune responses following percutaneous schistosome infection. Int J Parasitol 2015; 45: 215-224.
15. Davoine F & Lacy P. Eosinophil cytokines, chemokines, and growth factors: emerging roles in immunity. Front Immunol 2014; 5: 570.
16. Rothenberg ME & Hogan SP. The eosinophil. Annu Rev Immunol 2006; 24: 147-174.
17. Rosenberg HF, Dyer KD & Foster PS. Eosinophils: changing perspectives in health and disease. Nat Rev Immunol 2013; 13: 9-22.
18. Jacobsen EA, Helmers RA, Lee JJ & Lee NA. The expanding role(s) of eosinophils in health and disease. Blood 2012; 120: 3882-3890.
19. Jacobsen EA, Taranova AG, Lee NA & Lee JJ. Eosinophils: singularly destructive effector cells or purveyors of immunoregulation? J Allergy Clin Immunol 2007; 119: 1313-1320.
20. Kita H. Eosinophils: multifunctional and distinctive properties. Int Arch Allergy Immunol 2013; 161(Suppl 2): 3-9.
21. Klion AD & Nutman TB. The role of eosinophils in host defense against helminth parasites. J Allergy Clin Immunol 2004; 113: 30-37.
22. Swartz JM, Dyer KD, Cheever AW, et al. Schistosoma mansoni infection in eosinophil lineage-ablated mice. Blood 2006; 108: 2420-2427.
23. Cadman ET, Thysse KA, Bearder S, et al. Eosinophils are important for protection, immunoregulation and pathology during infection with nematode microfilariae. PLoS Pathog 2014; 10: e1003988.
24. Abraham SN & St John AL. Mast cell-orchestrated immunity to pathogens. Nat Rev Immunol 2010; 10: 440-452.
25. Galli SJ, Nakae S & Tsai M. Mast cells in the development of adaptive immune responses. Nat Immunol 2005; 6: 135-142.
26. Scholten J, Hartmann K, Gerbaulet A, et al. Mast cell-specific Cre/loxP-mediated recombination in vivo. Transgenic Res 2008; 17: 307-315.
27. Dudeck A, Dudeck J, Scholten J, et al. Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens. Immunity 2011; 34: 973-984.
28. Yu C, Cantor AB, Yang H, et al. Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo. J Exp Med 2002; 195: 1387-1395.
29. Mountford AP, Hogg KG, Coulson PS & Brombacher F. Signaling via interleukin-4 receptor alpha chain is required for successful vaccination against schistosomiasis in BALB/c mice. Infect Immun 2001; 69: 228-236.
30. Grimaldi JC, Yu NX, Grunig G, et al. Depletion of eosinophils in mice through the use of antibodies specific for C-C chemokine receptor 3 (CCR3). J Leukoc Biol 1999; 65: 846-853.
31. Mountford AP, Harrop R & Wilson RA. Antigens derived from lung-stage larvae of Schistosoma mansoni are efficient stimulators of proliferation and gamma interferon secretion by lymphocytes from mice vaccinated with attenuated larvae. Infect Immun 1995; 63: 1980-1986.
32. Hewitson JP, Jenkins GR, Hamblin PA & Mountford AP. CD40/CD154 interactions are required for the optimal maturation of skin-derived APCs and the induction of helminth-specific IFN-gamma but not IL-4. J Immunol 2006; 177: 3209-3217.
33. Hogg KG, Kumkate S, Anderson S & Mountford AP. Interleukin-12 p40 secretion by cutaneous CD11c+ and F4/80+ cells is a major feature of the innate immune response in mice that develop Th1-mediated protective immunity to Schistosoma mansoni. Infect Immun 2003; 71: 3563-3571.
34. Hashimoto D, Miller J & Merad M. Dendritic cell and macrophage heterogeneity in vivo. Immunity 2011; 35: 323-335.
35. Buch T, Heppner FL, Tertilt C, et al. A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration. Nat Methods 2005; 2: 419-426.
36. Cadman ET & Lawrence RA. Granulocytes: effector cells or immunomodulators in the immune response to helminth infection? Parasite Immunol 2010; 32: 1-19.
37. Fabre V, Beiting DP, Bliss SK, et al. Eosinophil deficiency compromises parasite survival in chronic nematode infection. J Immunol 2009; 182: 1577-1583.
38. Huang L, Gebreselassie NG, Gagliardo LF, et al. Eosinophil-derived IL-10 supports chronic nematode infection. J Immunol 2014; 193: 4178-4187.
39. Jacobsen EA, Zellner KR, Colbert D, Lee NA & Lee JJ. Eosinophils regulate dendritic cells and Th2 pulmonary immune responses following allergen provocation. J Immunol 2011; 187: 6059-6068.
40. Yang D, Rosenberg HF, Chen Q, Dyer KD, Kurosaka K & Oppenheim JJ. Eosinophil-derived neurotoxin (EDN), an antimicrobial protein with chemotactic activities for dendritic cells. Blood 2003; 102: 3396-3403.
41. Wang HB, Ghiran I, Matthaei K & Weller PF. Airway eosinophils: allergic inflammation recruited professional antigen-presenting cells. J Immunol 2007; 179: 7585-7592.
42. Padigel UM, Lee JJ, Nolan TJ, Schad GA & Abraham D. Eosinophils can function as antigen-presenting cells to induce primary and secondary immune responses to Strongyloides stercoralis. Infect Immun 2006; 74: 3232-3238.
43. Padigel UM, Hess JA, Lee JJ, et al. Eosinophils act as antigen-presenting cells to induce immunity to Strongyloides stercoralis in mice. J Infect Dis 2007; 196: 1844-1851.
44. Sher A, Coffman RL, Hieny S & Cheever AW. Ablation of eosinophil and IgE responses with anti-IL-5 or anti-IL-4 antibodies fails to affect immunity against Schistosoma mansoni in the mouse. J Immunol 1990; 145: 3911-3916.
45. Sabin EA, Kopf MA & Pearce EJ. Schistosoma mansoni egg-induced early IL-4 production is dependent upon IL-5 and eosinophils. J Exp Med 1996; 184: 1871-1878.
46. Paul C, Wolff S, Zapf T, et al. Mast cells have no impact on cutaneous leishmaniasis severity and related Th2 differentiation in resistant and susceptible mice. Eur J Immunol 2015; doi: 10.1002/eji.201545613.
47. Galli SJ, Grimbaldeston M & Tsai M. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol 2008; 8: 478-486.